HAS3 | Hyaluronan synthase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
HOXA1 | Homeobox A1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOXB8 | Homeobox B8 | Transcription factors
| | | | | Tissue enhanced |
HPGD | Hydroxyprostaglandin dehydrogenase 15-(NAD) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
HS6ST3 | Heparan sulfate 6-O-sulfotransferase 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
IL17A | Interleukin 17A | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL1RAPL2 | Interleukin 1 receptor accessory protein-like 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
IL26 | Interleukin 26 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL9R | Interleukin 9 receptor | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KRT17 | Keratin 17 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
KRTAP5-9 | Keratin associated protein 5-9 | | | | | | Tissue enhanced |
MMP13 | Matrix metallopeptidase 13 (collagenase 3) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP2 | Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MSX2 | Msh homeobox 2 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
MYO3B | Myosin IIIB | Enzymes
| | | | | Tissue enhanced |
OSTN | Osteocrin | Predicted secreted proteins
| | | | | Tissue enhanced |
P2RX1 | Purinergic receptor P2X, ligand-gated ion channel, 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
P4HA3 | Prolyl 4-hydroxylase, alpha polypeptide III | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PCP4 | Purkinje cell protein 4 | | | | | | Tissue enhanced |
PCP4L1 | Purkinje cell protein 4 like 1 | | | | | | Tissue enhanced |
PI16 | Peptidase inhibitor 16 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
RP11-1012A1.4 | | | | | | | Tissue enhanced |
RP11-680G10.1 | Uncharacterized protein | | | | | | Tissue enhanced |
RP11-685N3.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
SELE | Selectin E | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SFRP2 | Secreted frizzled-related protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
SHH | Sonic hedgehog | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLITRK6 | SLIT and NTRK-like family, member 6 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
SNCG | Synuclein, gamma (breast cancer-specific protein 1) | | | | | | Tissue enhanced |
SPOCD1 | SPOC domain containing 1 | | | | | | Tissue enhanced |
SPTSSB | Serine palmitoyltransferase, small subunit B | Predicted membrane proteins
| | | | | Tissue enhanced |
TMC1 | Transmembrane channel-like 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TRIM31 | Tripartite motif containing 31 | | | | | | Tissue enhanced |
TRPA1 | Transient receptor potential cation channel, subfamily A, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
UPK1B | Uroplakin 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
WNT5A | Wingless-type MMTV integration site family, member 5A | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
WNT7B | Wingless-type MMTV integration site family, member 7B | Predicted secreted proteins
| | | | | Tissue enhanced |